Frontlight ResearchEarly access
TerminatedNo phase
Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.
Key facts
- Who runs it
- Mustang Bio
- Where
- Boston, Cleveland, Orange, Rochester, and Seattle, United StatesSee the 5 sites
- Trial code
- Status
- Terminated
- People taking part
- 3 people enrolled
- Started
- 29 Sept 2021
- Ended
- 12 Apr 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Prior MB-102 CAR-T cell investigational product.
- Prior MB-106 CAR-T cell investigational product.
- Record updated
- 22 July 2024
- Why it stopped
- Business Reasons
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patients previously treated with a Mustang Bio CAR-T cell investigational product in a prior Mustang Bio sponsored clinical study
- Patient has provided signed and dated informed consent
Who cannot take part
- None. All patients who have received prior treatment with Mustang Bio CAR-T cell investigational product in a Mustang Bio sponsored clinical study are eligible for this long-term follow up (LTFU) study
Where in United States
- Massachusetts General HospitalBoston, United States
- Cleveland ClinicCleveland, United States
- UC Irvine Health- Chao Family Comprehensive Cancer CenterOrange, United States
- University of Rochester Medical CenterRochester, United States
- Fred Hutchinson Cancer CenterSeattle, United States
About the trial
What the trial wants to find out
A long-term follow-up study to assess safety and efficacy in patients previously treated with Mustang Bio chimeric antigen receptor (CAR)-T cell investigational products.
The 2 groups in the trial
- Prior MB-102 CAR-T cell investigational product.
Patients previously treated with MB-102 CAR-T cell investigational product.
- Prior MB-106 CAR-T cell investigational product.
Patients previously treated with MB-106 CAR-T cell investigational product.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Long-term Follow-up Study in Patients Previously Treated With Mustang Bio, Inc. CAR-T Cell Investigational Products
- Record updated
- 22 July 2024